The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define the procedure for validation of upstream processes used in biosimilar manufacturing, including cell culture, media preparation, inoculation, and bioreactor operations to ensure process consistency, reproducibility, and regulatory compliance.
Click to read the full article.
To define the procedure for systematic backup and restoration of electronic control systems used in upstream biosimilar manufacturing to ensure data integrity, continuity, and GMP compliance.
Click to read the full article.
To define a standardized procedure for monitoring power supply stability in the biosimilar upstream manufacturing area to prevent equipment malfunction, ensure continuous operations, and comply with GMP infrastructure requirements.
Click to read the full article.
To establish a standardized method for verifying the quality of compressed air used in upstream and downstream biosimilar manufacturing operations to ensure compliance with GMP and ISO 8573 air purity standards.
Click to read the full article.
To define the procedure for safe, accurate, and GMP-compliant preparation and handling of chemicals used in upstream biosimilar operations within the designated chemical preparation area.
Click to read the full article.
To establish a validated and standardized procedure for executing Steam-In-Place (SIP) of bioreactors, media transfer lines, and associated components used in biosimilar manufacturing to ensure sterility before use.
Click to read the full article.
To establish a procedure for the usage, monitoring, and documentation of Water for Injection (WFI) in biosimilar manufacturing processes, ensuring compliance with GMP, pharmacopeial, and microbiological standards.
Click to read the full article.
To define the procedure for sterile filtration of culture media used in upstream biosimilar processes to ensure removal of particulates and microbial contaminants prior to inoculation or cell culture applications.
Click to read the full article.
To establish a consistent and GMP-compliant procedure for reviewing, verifying, and approving batch production and control records prior to batch release in biosimilar manufacturing.
Click to read the full article.
To define the procedure for periodic review and verification of equipment maintenance logs to ensure compliance with preventive maintenance (PM) schedules, traceability, and GMP readiness in biosimilar manufacturing facilities.
Click to read the full article.